homocysteine 发表于 2025-3-30 08:32:22

http://reply.papertrans.cn/32/3187/318638/318638_51.png

竖琴 发表于 2025-3-30 14:17:33

http://reply.papertrans.cn/32/3187/318638/318638_52.png

FOLD 发表于 2025-3-30 18:12:01

http://reply.papertrans.cn/32/3187/318638/318638_53.png

忍耐 发表于 2025-3-30 21:21:20

http://reply.papertrans.cn/32/3187/318638/318638_54.png

single 发表于 2025-3-31 03:51:18

J. Nagarjun,S. Manimaran,M. Krishnaprakash patient to myotubes by MyoD transduction using fluorescence-activated cell sorting (FACS). We subsequently designed antisense PMOs targeting identical regions of dog and human dystrophin exons 6 and 8 and administered them as a cocktail to the in vitro generated dog or human myotubes. In both cases

全国性 发表于 2025-3-31 07:36:45

https://doi.org/10.1007/978-3-540-88087-5tiated myoblasts. Herein, we describe an optimized methodology to prepare myoblasts differentiated from iPS cells by mRNA transfection of the CRISPR-Cas9 system to skip exon 45 in myoblasts, and evaluate the restored dystrophin by RT-PCR and Western blotting.

canvass 发表于 2025-3-31 09:56:28

http://reply.papertrans.cn/32/3187/318638/318638_57.png

jocular 发表于 2025-3-31 16:13:07

http://reply.papertrans.cn/32/3187/318638/318638_58.png

Liberate 发表于 2025-3-31 19:11:03

http://reply.papertrans.cn/32/3187/318638/318638_59.png

智力高 发表于 2025-4-1 00:29:22

http://reply.papertrans.cn/32/3187/318638/318638_60.png
页: 1 2 3 4 5 [6]
查看完整版本: Titlebook: Exon Skipping and Inclusion Therapies; Methods and Protocol Toshifumi Yokota,Rika Maruyama Book 2018 Springer Science+Business Media, LLC,